Trilogy Capital Portfolio holdings
Trilogy Capital is an investment management firm that manages money for high net worth individuals and families as well as trusts, estates and profit-sharing plans, and it does business as Trilogy Financial. Jeff Motske established it in 2015; he had already co-founded the related financial planning company Trilogy Financial Services in 1999 with Kevin Mackintosh. Rather than picking everything itself, the firm builds globally diversified portfolios, graded by risk level, from a short list of institutional fund managers. It also offers financial coaching on budgeting, taxes, education and retirement, and runs retirement plan services for employers that sponsor 401(k) and similar plans.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$28.9M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$24.4M |
| 3 |
Defiance AI & Power Infrastructure ETF
AIPO
|
+$11.5M |
| 4 |
Vanguard Total Bond Market
BND
|
+$11M |
| 5 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$8.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$31.5M |
| 2 |
SPDR Gold Trust
GLD
|
+$23.1M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$20.1M |
| 4 |
State Street Multi-Asset Real Return ETF
RLY
|
+$10.6M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.36% |
| 2 | Technology | 5.68% |
| 3 | Healthcare | 2.26% |
| 4 | Consumer Discretionary | 1.45% |
| 5 | Financials | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Invesco Investment Grade Defensive ETF
IIGD
$24.1M
| $785K | 0.03% |
33,024
-100
| -0.3% | -$2.42K |
2021 Q2
21 quarters
|
|
227
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.48B
| $777K | 0.03% |
4,843
-151
| -3% | -$25.9K |
2026 Q2
1 quarter
|
|
228
iShares ESG Aware MSCI USA ETF
ESGU
$17.7B
| $774K | 0.03% |
4,642
-63
| -1% | -$10.5K |
2020 Q1
26 quarters
|
|
229
Walmart Inc
WMT
$997B
| $762K | 0.03% |
7,334
-17
| -0.2% | -$1.87K |
2023 Q2
13 quarters
|
|
230
Alerian MLP ETF
AMLP
$12.2B
| $754K | 0.03% |
14,532
| – | – |
2024 Q2
9 quarters
|
|
231
PUT
ExxonMobil
XOM
$672B
| $749K | 0.03% |
+4,600
| New | +$719K |
2026 Q3
0 quarters
|
|
232
F/m US Treasury 3 Month Bill Fund
TBIL
$7.5B
| $737K | 0.03% |
14,785
-424
| -3% | -$21.2K |
2025 Q2
5 quarters
|
|
233
Global X Russell 2000 Covered Call ETF
RYLD
$1.3B
| $735K | 0.03% |
47,526
+25
| +0.1% | +$401 |
2024 Q2
9 quarters
|
|
234
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.1B
| $716K | 0.03% |
17,097
+808
| +5% | +$33.5K |
2025 Q4
3 quarters
|
|
235
Marathon Petroleum
MPC
$106B
| $704K | 0.03% |
1,779
+4
| +0.2% | +$1.38K |
2025 Q1
6 quarters
|
|
236
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.6B
| $701K | 0.03% |
2,074
-819
| -28% | -$286K |
2024 Q2
9 quarters
|
|
237
Thermo Fisher Scientific
TMO
$267B
| $686K | 0.03% |
1,016
+6
| +0.6% | +$3.56K |
2022 Q3
16 quarters
|
|
238
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$575M
| $679K | 0.03% |
7,325
+12
| +0.2% | +$1.11K |
2022 Q4
15 quarters
|
|
239
iShares S&P 500 Growth ETF
IVW
$73.6B
| $677K | 0.03% |
4,758
-297
| -6% | -$41.2K |
2023 Q2
13 quarters
|
|
240
Qualcomm
QCOM
$183B
| $667K | 0.03% |
3,623
+57
| +2% | +$9.9K |
2023 Q2
13 quarters
|
|
241
PGIM Ultra Short Bond ETF
PULS
$19.8B
| $658K | 0.03% |
13,312
-7,212
| -35% | -$358K |
2024 Q1
10 quarters
|
|
242
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.93B
| $651K | 0.03% |
9,499
+146
| +2% | +$10.1K |
2017 Q4
35 quarters
|
|
243
WisdomTree Emerging Markets Local Debt Fund
ELD
$129M
| $647K | 0.02% |
23,204
-901
| -4% | -$25.8K |
2026 Q1
2 quarters
|
|
244
Innovator US Equity Buffer ETF July
BJUL
$356M
| $642K | 0.02% |
+11,585
| New | +$638K |
2026 Q3
0 quarters
|
|
245
Abbott
ABT
$191B
| $642K | 0.02% |
6,496
+1,742
| +37% | +$182K |
2024 Q2
9 quarters
|
|
246
iShares Russell 2000 ETF
IWM
$78.5B
| $638K | 0.02% |
2,295
-241
| -10% | -$70.8K |
2020 Q2
25 quarters
|
|
247
THOR Low Volatility ETF
THLV
$55.5M
| $637K | 0.02% |
20,440
-2,064
| -9% | -$67.2K |
2022 Q4
15 quarters
|
|
248
Williams Companies
WMB
$83.1B
| $629K | 0.02% |
9,249
+41
| +0.4% | +$2.98K |
2025 Q1
6 quarters
|
|
249
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.32B
| $619K | 0.02% |
6,362
-153
| -2% | -$15K |
2017 Q4
35 quarters
|
|
250
Trane Technologies
TT
$92.1B
| $617K | 0.02% |
1,365
+9
| +0.7% | +$4.14K |
2024 Q2
9 quarters
|
|
Similar funds
Trilogy Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Trilogy Capital held 433 positions worth $2.61B, up 1.1% from $2.58B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trilogy Capital's Q3 2026 filing shows 30 new, 223 increased, 129 reduced and 24 closed positions. Its largest new stake was Defiance AI & Power Infrastructure ETF: 392,912 shares worth $11.1M. The largest sale was Berkshire Hathaway Class B, an estimated $31.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, up from 84% a quarter earlier, followed by Technology and Healthcare.
- Trilogy Capital's largest Q3 2026 buy was Defiance AI & Power Infrastructure ETF: 392,912 shares worth $11.1M.
- Trilogy Capital added most to Invesco S&P 500 Momentum ETF in Q3 2026, an estimated $28.9M increase.
- Trilogy Capital's biggest Q3 2026 reduction was Berkshire Hathaway Class B, cutting an estimated $31.5M.
- Trilogy Capital fully exited Global X Uranium ETF in Q3 2026, selling an estimated $4.81M.
- Trilogy Capital's ten largest holdings make up 40% of its $2.61B portfolio in Q3 2026.
- Trilogy Capital opened 30 new positions and closed 24 in Q3 2026.
- Trilogy Capital's portfolio value rose 1.1% quarter-over-quarter to $2.61B.
Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.